Bonness Enterprises’s Bristol-Myers Squibb BMY Stock Holding History

Bonness Enterprises’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.13M	Hold	54,300	–	–	1.01%	18
2026 Q1	$3.29M	Hold	54,300	–	–	1.21%	19
2025 Q4	$2.93M	Hold	54,300	–	–	1.01%	19
2025 Q3	$2.45M	Hold	54,300	–	–	0.8%	23
2025 Q2	$2.51M	Hold	54,300	–	–	0.82%	21
2025 Q1	$3.31M	Hold	54,300	–	–	1.08%	18
2024 Q4	$3.07M	Hold	54,300	–	–	1.08%	19
2024 Q3	$2.81M	Hold	54,300	–	–	0.93%	22
2024 Q2	$2.26M	Hold	54,300	–	–	0.83%	23
2024 Q1	$2.94M	Hold	54,300	–	–	1.06%	19
2023 Q4	$2.79M	Hold	54,300	–	–	1.17%	19
2023 Q3	$3.15M	Hold	54,300	–	–	1.44%	19
2023 Q2	$3.47M	Hold	54,300	–	–	1.56%	19
2023 Q1	$3.76M	Hold	54,300	–	–	1.68%	16
2022 Q4	$3.91M	Hold	54,300	–	–	1.84%	14
2022 Q3	$3.86M	Sell	54,300 -500	-0.9%	-$36.3K	2.05%	9
2022 Q2	$4.22M	Hold	54,800	–	–	2.11%	10
2022 Q1	$4M	Hold	54,800	–	–	1.84%	16
2021 Q4	$3.42M	Buy	54,800 +1,700	+3%	+$99.7K	1.58%	19
2021 Q3	$3.14M	Hold	53,100	–	–	1.6%	19
2021 Q2	$3.55M	Hold	53,100	–	–	1.79%	18
2021 Q1	$3.35M	Hold	53,100	–	–	1.79%	17
2020 Q4	$3.29M	Hold	53,100	–	–	1.84%	15
2020 Q3	$3.2M	Hold	53,100	–	–	1.88%	13
2020 Q2	$3.12M	Hold	53,100	–	–	2%	13
2020 Q1	$2.96M	Hold	53,100	–	–	2.14%	12
2019 Q4	$3.41M	Hold	53,100	–	–	2.14%	12
2019 Q3	$2.69M	Hold	53,100	–	–	1.73%	16
2019 Q2	$2.41M	Hold	53,100	–	–	1.5%	18
2019 Q1	$2.53M	Hold	53,100	–	–	1.65%	18
2018 Q4	$2.76M	Hold	53,100	–	–	2.08%	13
2018 Q3	$3.3M	Hold	53,100	–	–	2.16%	14
2018 Q2	$2.94M	Hold	53,100	–	–	2.08%	13
2018 Q1	$3.36M	Sell	53,100 -1,000	-2%	-$64.3K	2.34%	11
2017 Q4	$3.31M	Hold	54,100	–	–	2.25%	10
2017 Q3	$3.45M	Hold	54,100	–	–	2.47%	10
2017 Q2	$3.01M	Hold	54,100	–	–	2.31%	11
2017 Q1	$2.94M	Hold	54,100	–	–	2.35%	11
2016 Q4	$3.16M	Sell	54,100 -5,920	-10%	-$324K	2.84%	8
2016 Q3	$3.24M	Hold	60,020	–	–	2.69%	10
2016 Q2	$4.41M	Hold	60,020	–	–	3.71%	5
2016 Q1	$3.83M	Hold	60,020	–	–	3.3%	6
2015 Q4	$4.13M	Hold	60,020	–	–	3.72%	6
2015 Q3	$3.55M	Hold	60,020	–	–	3.39%	5
2015 Q2	$3.99M	Sell	60,020 -7,000	-10%	-$461K	3.6%	6
2015 Q1	$4.32M	Hold	67,020	–	–	3.84%	6
2014 Q4	$3.96M	Sell	67,020 -1,000	-1%	-$56.4K	3.42%	6
2014 Q3	$3.48M	Hold	68,020	–	–	3.13%	6
2014 Q2	$3.3M	Sell	68,020 -5,000	-7%	-$246K	2.99%	8
2014 Q1	$3.79M	Hold	73,020	–	–	3.33%	7
2013 Q4	$3.88M	Sell	73,020 -200	-0.3%	-$10.2K	3.43%	7
2013 Q3	$3.39M	Hold	73,220	–	–	3.26%	7
2013 Q2	$3.27M	Buy	+73,220	New	+$3.18M	3.24%	7

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Bonness Enterprises's BMY Position: Q2 2026 in Review

Bonness Enterprises held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 54,300 shares worth $3.13M. The position accounts for 1.01% of the portfolio, ranked #18.

Bonness Enterprises first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.41M in Q2 2016. 1,170 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Bonness Enterprises held 54,300 shares of Bristol-Myers Squibb worth $3.13M as of Q2 2026.
Bonness Enterprises left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 1.01% of Bonness Enterprises's portfolio in Q2 2026, its #18 holding.
Bonness Enterprises first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
Bonness Enterprises's Bristol-Myers Squibb position peaked at $4.41M in Q2 2016.
1,170 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Bonness Enterprises's 13F filing for Q2 2026, filed 9 Jul 2026.